Galbraith Kenneth
SEC insider (Form 3/4/5 filer). CIK 0001567045. Chair & CEO at Zymeworks Inc. (ZYME). 17 reported Form 4/5 transactions since Sep 2024; latest on Jan 12, 2026. Located in MIDDLETOWN, DE.
Companies Galbraith Kenneth has filed insider reports for
- Zymeworks Inc. (ZYME): Director, Officer, Chair & CEO
Galbraith Kenneth
CIK: 0001567045
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Zymeworks Inc.
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
216K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
SaleDirect30.4K shares at avg. $22.67$690K - Jan 12, 2026ZYME
Zymeworks Inc.
ExerciseDirect64K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectPerformance Stock Unit
222K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
144K shares- - Jan 5, 2026ZYME
Zymeworks Inc.
SaleDirect31.7K shares at avg. $25.10$795K - Jan 5, 2026ZYME
Zymeworks Inc.
ExerciseDirect47.7K shares- - Jan 5, 2026ZYME
Zymeworks Inc.
SaleDirect22.7K shares at avg. $25.10$569K - Jan 5, 2026ZYME
Zymeworks Inc.
ExerciseDirect66.7K shares- - Dec 22, 2025ZYME
Zymeworks Inc.
ExerciseDirect100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 216,000 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Sale | 30,424 | $22.67 | $689,819 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Exercise | 64,000 | - | $0 | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Performance Stock Unit | 222,000 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 144,000 | - | - | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Sale | 31,686 | $25.10 | $795,220 | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Exercise | 47,668 | - | $0 | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Sale | 22,657 | $25.10 | $568,620 | Direct |
| Jan 5, 2026 | ZYME Zymeworks Inc. | Exercise | 66,666 | - | $0 | Direct |
| Dec 22, 2025 | ZYME Zymeworks Inc. | Exercise | 100,000 | - | - | Direct |
1-10 of 17 transactions